SAB Stock Overview
Offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Sonic Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$16.28 |
| 52 Week High | AU$19.70 |
| 52 Week Low | AU$14.10 |
| Beta | 0.51 |
| 1 Month Change | -5.20% |
| 3 Month Change | 1.02% |
| 1 Year Change | -14.84% |
| 3 Year Change | -43.86% |
| 5 Year Change | -10.54% |
| Change since IPO | 129.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| SAB | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -1.4% | -3.7% | -2.0% |
| 1Y | -14.8% | 15.8% | 6.8% |
Return vs Industry: SAB underperformed the German Healthcare industry which returned 15.6% over the past year.
Return vs Market: SAB underperformed the German Market which returned 6.9% over the past year.
Price Volatility
| SAB volatility | |
|---|---|
| SAB Average Weekly Movement | 3.8% |
| Healthcare Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: SAB has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: SAB's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1934 | 42,000 | Colin Goldschmidt | www.sonichealthcare.com |
Sonic Healthcare Limited offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services.
Sonic Healthcare Limited Fundamentals Summary
| SAB fundamental statistics | |
|---|---|
| Market cap | €7.90b |
| Earnings (TTM) | €306.92m |
| Revenue (TTM) | €5.39b |
25.8x
P/E Ratio1.5x
P/S RatioIs SAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SAB income statement (TTM) | |
|---|---|
| Revenue | AU$8.97b |
| Cost of Revenue | AU$6.02b |
| Gross Profit | AU$2.94b |
| Other Expenses | AU$2.43b |
| Earnings | AU$511.09m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.06 |
| Gross Margin | 32.84% |
| Net Profit Margin | 5.70% |
| Debt/Equity Ratio | 37.0% |
How did SAB perform over the long term?
See historical performance and comparisonDividends
3.9%
Current Dividend Yield99%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 13:52 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sonic Healthcare Limited is covered by 31 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dennis Hulme | APP Securities Pty Ltd. |
| Russell Wright | Barclay Pearce Capital Pty Limited |
| Benjamin Brayshaw | Barrenjoey Markets Pty Limited |